Diabetes stories
People with diabetes in Australia and Singapore may soon get more connected care as glucose data is linked to digital management tools.
The milestone underscores rising demand for cheaper glucose monitors as Ottai pushes into overseas markets including Malaysia and Australia.
Salesforce has rolled out Agentforce 2dx, a cutting-edge digital labour platform that integrates AI agents into business workflows for enhanced efficiency.
AI agents are set to transform daily life across sectors, optimising everything from smart homes to personalised shopping, according to Raphael Allstadt.
The peptide Active Pharmaceutical Ingredient market is poised for significant growth, driven by demand for targeted therapies and advances in synthesis technology.
The grant backs an effort to overcome a key hurdle in mitochondrial medicine, where faulty genes remain hard to reach inside the organelle.
Grassroots groups will get Canon equipment and funding to back projects from sea turtle rescue to student journalism and First Nations healing.
Patients at selected Tāmaki Health clinics can now get round-the-clock coaching between appointments as demand for primary care rises.
Funding will back trials and regulatory work as the New Zealand start-up aims to bring a smaller, reusable insulin device to the US market.
Patients face longer waits and higher costs as underfunded primary care strains health systems and worsens preventable disease.
The platform is now used across 16 NHS organisations as services expand heart failure, COPD and virtual ward monitoring into community care.
The funding will help expand Vancouver research, manufacturing and clinical trials, with hundreds of jobs and student co-op places expected to follow.
Australian people with type 1 diabetes can now choose a smaller sensor that reduces finger-prick checks and links to an insulin pump.
Zoom Health is urging an overhaul of New Zealand's pharmacy funding as 12‑month prescriptions loom, warning closures and care gaps will grow.
New Zealand's employee health plan costs are set to surge 18% in 2026, far exceeding the Asia Pacific and global averages amid rising healthcare demands.
Sol Menopause launches its app in Asia, offering medically reviewed support to women and employers for menopause health and inclusive workplaces.
Australians with diabetes can now monitor glucose levels and receive alerts directly on their Apple Watch through new Dexcom G7 integration.
Dexcom's latest innovation, the ONE+, is set to transform diabetes management in Australia by offering real-time glucose monitoring and alerts for Type 2 diabetes.
AI diagnostics is transforming healthcare by enhancing accuracy, speeding up disease detection, and reducing errors across lab tests, imaging, and genomics.
Dexcom has launched its Dexcom ONE+ continuous glucose monitoring system in Australia, enhancing glucose management for those with Type 2 diabetes.
